Alimentary pharmacology & therapeutics

Aliment Pharmacol Ther · ISSN (e) 1365-2036 · 9 papers in corpus
nonrandomized-trial 2026
doi:10.1111/apt.70831 ·PMID:42482523

BACKGROUND: Treatment options for medically-refractory faecal incontinence (FI)-including anorectal biofeedback, dextranomer injection, and sacral nerve stimulation-are limited and outcomes are often suboptimal. Anal or vaginal insert devic…

other 2026
doi:10.1111/apt.70419 ·PMID:41288306
rct 2025
doi:10.1111/apt.70161 ·PMID:40319391

BACKGROUND: Gastrointestinal symptoms affect most women with endometriosis, but therapeutic interventions are poorly defined. AIMS: To compare the effects of a 28-day low fermentable oligo-, di- and mono-saccharides and polyols (FODMAP) or…

observational 2025
doi:10.1111/apt.70277 ·PMID:41081454

We compared ovarian cancer incidence between women with and without an index irritable bowel syndrome (IBS) diagnosis using administrative claims data. Risk of ovarian cancer was higher at 3 (hazard ratio [HR] = 1.71, 95% CI: 1.08-2.70, p =…

observational 2025
doi:10.1111/apt.70053 ·PMID:40013754

BACKGROUND: There is a female predominance of diagnosed coeliac disease with sex-related differences in clinical presentation. Delayed menarche, infertility and pregnancy complications have been linked to poor nutritional status and autoimm…

observational 2022
doi:10.1111/apt.16647 ·PMID:34662440

BACKGROUND: How contraceptive formulation, dose, duration of therapy and mode of delivery affects the risk of inflammatory bowel disease (IBD) is poorly described. AIM: To examine associations between types of hormonal contraception and de…

observational 2019
doi:10.1111/apt.15229 ·PMID:30908719

BACKGROUND: Off-label prescribing is encountered across various fields of medicine and creates alternative treatment options, but is associated with unknown safety risks. The use of off-label drugs for the treatment of patients with inflamm…

rct 2012
doi:10.1111/j.1365-2036.2012.05202.x ·PMID:22762290

BackgroundPancreatic exocrine insufficiency (PEI) results in maldigestion, leading to abdominal pain, steatorrhoea, malnutrition and weight loss.AimTo assess the efficacy and safety of pancreatin (Creon 40000 MMS) in treating PEI due to chr…

observational 2009
doi:10.1111/j.1365-2036.2008.03847.x ·PMID:18785989

BACKGROUND: The burden of functional GI disorders and their associations with psychological distress in women veterans is unclear. AIM: To examine 1-year prevalence of irritable bowel syndrome (IBS) and dyspepsia symptoms and their associa…